Alumni Ventures's Pharmaceutical Portfolio

Introducing a game changing opioid overdose rescue product that opens a new $1B opportunity

GRO Biosciences is a biotechnology company that develops a protein therapeutics technology to improve treatments across multiple diseases.

PharmaCCX operates a market access platform with a simple and configurable infrastructure for planning, negotiating, and managing deals.

Florence is a clinical trials platform that connects pharmaceutical companies and study sites to decentralize trials for drug development.

Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes.

Clinical Maestro™ by Strategikon Pharma is the only commercially available software platform for clinical trial business management.

Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.

Gilgamesh Pharmaceuticals is a clinical-stage biotechnology company that develops psychedelic and related drugs to treat mental illnesses.

Emulate creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.